NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.66%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.41B
AUM Growth
+$204M
(+17%)
Cap. Flow
+$59.3M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
37.13%
Holding
155
New
17
Increased
44
Reduced
11
Closed
8
Top Buys
| 1 |
Xtant Medical Holdings
XTNT
|
+$42.1M |
| 2 |
JCAP
Jefferson Capital, Inc. Common Stock
JCAP
|
+$11.1M |
| 3 |
TriSalus Life Sciences
TLSI
|
+$10.9M |
| 4 |
Jack in the Box
JACK
|
+$10.5M |
| 5 |
1-800-Flowers.com
FLWS
|
+$9.84M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$63.3M |
| 2 |
Gogo Inc
GOGO
|
+$37M |
| 3 |
UroGen Pharma
URGN
|
+$18.6M |
| 4 |
RH
RH
|
+$11.8M |
| 5 |
uniQure
QURE
|
+$9.82M |
Sector Composition
| 1 | Healthcare | 63.53% |
| 2 | Consumer Discretionary | 15.72% |
| 3 | Communication Services | 5.76% |
| 4 | Financials | 5.29% |
| 5 | Industrials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDNW
51
RideNow Group, Inc. Class B Common Stock
RDNW
$148M
| $7.56M | 0.3% |
3,272,845
| – | – |
|
52
Fossil Group
FOSL
$159M
| $7.53M | 0.3% |
5,087,803
+898,626
| +21% | +$1.33M |
|
53
Apyx Medical
APYX
$77.9M
| $7.51M | 0.29% |
3,338,048
+80,000
| +2% | +$180K |
|
|
CNTA
54
Centessa Pharmaceuticals
CNTA
$2.8B
| $7.29M | 0.29% |
554,803
| – | – |
|
55
Akebia Therapeutics
AKBA
$795M
| $7.28M | 0.29% |
2,000,000
| – | – |
|
56
Dyne Therapeutics
DYN
$1.88B
| $7.09M | 0.28% |
745,062
+400,000
| +116% | +$3.81M |
|
57
Herbalife
HLF
$977M
| $7.09M | 0.28% |
822,298
+722,298
| +722% | +$6.23M |
|
58
Syndax Pharmaceuticals
SNDX
$1.37B
| $7.07M | 0.28% |
754,503
+200,000
| +36% | +$1.87M |
|
59
DHI Group
DHX
$135M
| $7.05M | 0.28% |
2,374,027
| – | – |
|
60
Alta Equipment Group
ALTG
$250M
| $6.59M | 0.26% |
1,042,769
| – | – |
|
|
UPB
61
Upstream Bio, Inc. Common Stock
UPB
$983M
| $6.53M | 0.26% |
594,971
| – | – |
|
62
Xencor
XNCR
$593M
| $6.45M | 0.25% |
820,103
+363,362
| +80% | +$2.86M |
|
63
Viemed Healthcare
VMD
$260M
| $6.44M | 0.25% |
932,445
| – | – |
|
|
AVR
64
Anteris Technologies Global Corp. Common Stock
AVR
$167M
| $6.42M | 0.25% |
1,693,666
+30,000
| +2% | +$114K |
|
65
Elutia
ELUT
$62.7M
| $6.31M | 0.25% |
3,184,947
| – | – |
|
66
ADC Therapeutics
ADCT
$373M
| $6.07M | 0.24% |
+2,266,289
| New | +$6.07M |
|
|
SLN
67
Silence Therapeutics
SLN
$246M
| $6.05M | 0.24% |
1,042,427
| – | – |
|
|
ITOS
68
DELISTED
iTeos Therapeutics
ITOS
| $5.95M | 0.23% |
+596,666
| New | +$5.95M |
|
69
Distribution Solutions Group
DSGR
$1.44B
| $5.79M | 0.23% |
+210,800
| New | +$5.79M |
|
70
Astria Therapeutics
ATXS
$425M
| $5.73M | 0.22% |
1,069,530
+400,000
| +60% | +$2.14M |
|
|
THTX
71
Theratechnologies
THTX
$150M
| $5.72M | 0.22% |
2,422,563
| – | – |
|
72
eHealth
EHTH
$119M
| $5.7M | 0.22% |
1,311,441
| – | – |
|
73
Assertio
ASRT
$76.9M
| $5.65M | 0.22% |
8,810,073
+370,311
| +4% | +$237K |
|
|
PVLA
74
Palvella Therapeutics, Inc. Common Stock
PVLA
$627M
| $5.64M | 0.22% |
250,062
| – | – |
|
75
EyePoint Pharmaceuticals
EYPT
$978M
| $5.58M | 0.22% |
593,091
| – | – |
|